Fingerprint
Dive into the research topics of 'Bevacizumab versus ranibizumab for the treatment of neovascular age-related macular degeneration'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bevacizumab versus ranibizumab for the treatment of neovascular age-related macular degeneration
Uri Soiberman*, Anat Loewenstein
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review
1
Scopus
citations